Popular Searches:  AIG  china  sunamerica+aig  LIFE  financial  health

Cooper Gay Acquires Majority Stake in Reinsurance Broker

 

Friday, Oct 23,2009, 10:00:18 AM   Click:

Insurance and reinsurance broker Cooper Gay Holdings Ltd. said it's acquired the majority stake in a Florida-based reinsurance broker that specializes in the Argentina market.

Terms were not disclosed.

Cooper Guy said it acquired the stake in Reinsurance.com.ar LLC, which has offices in Miami and Buenos Aries.

Reinsurance.com.ar was established in 2006 by Guillermo Pastore, formerly chief operating officer of EW Blanch and Benfield Greig in Argentina. The company focuses on treaty and facultative reinsurance solutions, primarily for the Argentine market. Pastore will continue as chief executive officer.

"We have worked closely with Guillermo Pastore over the past two years, and have been impressed by the commitment, professionalism and drive of his entire team. I am delighted that we have moved to a majority shareholding in the company, further enhancing our ability to support the reinsurance requirements of this fast-growing region," Toby Esser, Cooper Gay's group CEO, said in a statement.

Attempts to reach the company for additional information were not immediately successful.

With $121.2 million in brokerage revenues for 2008, Cooper Gay ranked as the fifth-largest global reinsurance broker (Best's Review, August 2009).

In May, U.K.-based broker Cooper Gay said its 2008 profit rose 22% on growth in Germany and Eastern Europe, despite the impact of the ongoing global financial crisis on some insurance lines (BestWire, May 6, 2009).

  • Print

You may also be interested in:

Discuss this news

Click Here to see all comments
Please aware of self to obey the Internet related policy laws and strictly forbid to release porn, violence.
Appraisal:

Name:

Email:

Content:

Featured

Copyright: PR Newswire Source: PR Newswire Wordcount: 975 Three-year partnership to replicate in schools in underserved communities Tallahassee, Florida, March 27 / PRNewswire-USNewswire / -

Good Neighbors at State Farm $ 250,000 Grant for

Copyright: PR Newswire Source: PR Newswire Wordcount: 975 Three-year

Copyright 2009 TheStreet.com, Inc.All Rights Reserved TheStreet.com 28 March 2009 Saturday 11:52 AM EST SECTION: MARKETS; Market characteristics LENGTH: 733 words TITLE: Bankers Vow to Work With

Bankers hope to work with Obama

Copyright 2009 TheStreet.com, Inc.All Rights Reserved TheStreet.com 28 March

OLDWICK, N.J.--(BUSINESS WIRE)-- A.M. Best Co. has revised the outlook to negative from stable and affirmed the financial strength rating (FSR) of A+ (Superior) and issuer credit ratings (ICR) of

A.M. Best Revises Outlook to Negative for AXA

OLDWICK, N.J.--(BUSINESS WIRE)-- A.M. Best Co. has revised the outlook to

TALLAHASSEE - Floridians dealing with the mess of Chinese drywall could be facing a double-whammy, the state's insurance commissioner said Tuesday. Not only do the insurers have no obligation to

Toxic Drywall Might Have Insurance Repercussions

TALLAHASSEE - Floridians dealing with the mess of Chinese drywall could be

CHICAGO - (BUSINESS WIRE) - March 26, 2009 - Fitch Ratings has downgraded the Insurer Financial Strength (IFS) rating of Attorneys Title Insurance Fund, Inc. (the Fund) at 'CCC' from 'BBB'. The

Fitch decline Attorneys' Title IFS to 'CCC'

CHICAGO - (BUSINESS WIRE) - March 26, 2009 - Fitch Ratings has downgraded the

Copyright: Business Wire Source: Business Wire Wordcount: WALTHAM, Mass.--(BUSINESS WIRE)-- Guardium, the database security company, today announced continuing customer momentum for its database

Guardium for Momentum Fuels customer database by IBM

Copyright: Business Wire Source: Business Wire Wordcount: WALTHAM,

NEW YORK_The battle over the patent on Merck and Co.'s allergy and asthma drug Singulair, the best-selling drug of one of the world's largest drug makers, continued Friday as a group of drug

Merck sued over patent on allergy drug Singulair

NEW YORK_The battle over the patent on Merck and Co.'s allergy and asthma drug

MOST POPULAR